RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGIO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Agios Pharmaceuticals stock price ended at $29.12 on Wednesday, after gaining 0.206%.
(Updated on Mar 27, 2024)

Sell candidate since Mar 26, 2024 Gain 0.21% PDF

The Agios Pharmaceuticals stock price gained 0.206% on the last trading day (Wednesday, 27th Mar 2024), rising from $29.06 to $29.12. During the last trading day the stock fluctuated 2.96% from a day low at $28.57 to a day high of $29.42. The price has been going up and down for this period, and there has been a -2.93% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 93 thousand more shares were traded than the day before. In total, 647 thousand shares were bought and sold for approximately $18.85 million.

Given the current short-term trend, the stock is expected to rise 40.21% during the next 3 months and, with a 90% probability hold a price between $40.83 and $54.15 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AGIO Signals & Forecast

Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Agios Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $29.76 and $29.48. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -16.35%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Agios Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $26.80 and $25.15. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Agios Pharmaceuticals finds support just below today's level at $26.80. If this is broken, then the next support from accumulated volume will be at $25.15 and $24.02.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.84 between high and low, or 2.96%. For the last week, the stock has had daily average volatility of 3.43%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AGIO) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Agios Pharmaceuticals to open at $29.04, and during the day (based on 14 day Average True Range), to move between $27.95 and $30.29, which gives a possible trading interval of +/-$1.17 (+/-4.02%) up or down from last closing price. If Agios Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 8.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $29.78 (2.27%) than the support at $26.80 (7.97%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Agios Pharmaceuticals stock A Buy?

The Agios Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Agios Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.541 Sell Candidate Unchanged

Predicted Opening Price for Agios Pharmaceuticals of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$29.04 ( 0.292%) $29.12

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AGIO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 29.88 2.61 %
R2 29.56 1.50 %
R1 29.36 0.82 %
Current price: 29.12
Support S1 28.71 -1.40 %
S2 28.51 -2.09 %
S3 28.19 -3.19 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 32.99 13.29 %
R2 31.79 9.17 %
R1 29.78 2.27 %
Current price 29.12
Support S1 26.80 -7.97%
S2 25.15 -13.63%
S3 24.02 -17.51%

FAQ

What is the symbol for Agios Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Agios Pharmaceuticals is AGIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agios Pharmaceuticals Stock?
The Agios Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Agios Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Agios Pharmaceuticals Stock?
Agios Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agios Pharmaceuticals Stock.

What's the current price of Agios Pharmaceuticals Stock?
As of the end of day on the 2024-03-27, the price of an Agios Pharmaceuticals (AGIO) share was $29.12.

What is the 52-week high and low for Agios Pharmaceuticals Stock?
The 52-week high for Agios Pharmaceuticals Stock is $35.48 and the 52-week low is $19.80.

What is the market capitalization of Agios Pharmaceuticals Stock?
As of the 2024-03-27, the market capitalization of Agios Pharmaceuticals is 1.619B.

When is the next earnings date for Agios Pharmaceuticals?
The upcoming earnings date for Agios Pharmaceuticals is May 02, 2024.
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT